Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy

Trial Profile

Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 23 Nov 2017

At a glance

  • Drugs RAAV2 ND4 (Primary)
  • Indications Leber's hereditary optic atrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top